Pre-Marketing Clinical Safety 2016 is a conference dedicated to all the regulations and guidelines pertinent to pre-marketing safety in the EU.
Pre-Marketing Clinical Safety 2016 covers topics such as:
- Unblinding strategies
- Management of adverse events
- The role of ethics committees
- SUSARs reporting
- EudraVigilance CT module
- Development safety update reports
- Safety risk management
- Risk assessment in clinical trials
- Who should attend?
Pre-Marketing Clinical Safety 2016 brings together:
- Drug safety managers, specialists and directors involved in clinical trials Clinical trial monitors and managers wishing to acquire deeper knowledge of drug safety science and regulations Pharmacovigilance professionals involved in pre-marketing safety
